Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone markers and Zoledronic acid in metastatic breast cancer
NCT00912938Phase 4Unknown
- Sponsor
- Korean Breast Cancer Study Group
- Start
- Dec 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in breast cancer, sponsored by Korean Breast Cancer Study Group. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00912938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00912938.